UBS, Advances

UBS Advances Credit Suisse Legacy Cleanup as Analysts Turn More Bullish Ahead of Earnings

Published on 10/11/2026 at 16:10 | Editorial boerse-global.de

UBS shares gained 2.4% to EUR 42.96 on Friday, narrowing the gap to their 52-week high to 11%, ahead of Q3 results on October 28.

Moderner Bankschalter mit Glaspartitionen und Stahltresor im Hintergrund
UBS Group AG CH0244767585 zeigt einen modernen Bankschalterbereich mit eleganten Glaspartitionen und massiver Stahl-Tresortür Illustration mit AI erstellt.

UBS shares climbed 2.4% to EUR 42.96 on Friday, lifted by a broad recovery across European equity markets rather than any company-specific catalyst. Falling crude prices and easing geopolitical tensions in the Middle East provided the tailwind, with Reuters reporting that leading European indices gained roughly 1% on the day. The advance narrowed the stock's gap to its 52-week high of EUR 48.19 to 11%.

Investor attention is now shifting toward the Swiss bank's third-quarter results, scheduled for release on October 28, which should offer clearer insight into both operating momentum and the pace of post-Credit Suisse integration.

Northern Trust to Absorb Swiss and Luxembourg Fund Units

On the operational front, UBS confirmed Tuesday that it has struck a deal to transfer the former Credit Suisse fund administration operations in Switzerland and Luxembourg to US-based Northern Trust. The agreement marks a complete exit from that line of business for the Swiss lender.

Completion remains contingent on approval from the relevant supervisory authorities, with both institutions targeting the second quarter of 2027 for the formal close. The disposal fits into UBS's broader push to wind down or divest non-core units, part of an effort to reduce complexity and costs following the emergency takeover of its rival.

Should investors sell immediately? Or is it worth buying UBS?

Brokerages Lift Price Targets

Analysts have turned more constructive on the stock in recent sessions. JPMorgan reaffirmed its "Overweight" rating on Tuesday with a price target of CHF 50, updating its models ahead of the October 28 earnings date. Deutsche Bank Research followed on Wednesday, with analyst Benjamin Goy raising his target to CHF 47 from CHF 45 while keeping a "Buy" recommendation. Goy pointed to the bank's operating performance and the anticipated impact of forthcoming regulatory requirements as key drivers behind the revision.

Capital Rules Remain the Long-Term Wildcard

Looming over the strategic outlook is the ongoing debate in Bern over stricter capital adequacy rules. Roughly two weeks ago, the Swiss Council of States backed proposals that would require foreign subsidiaries to be backed by 90% hard core capital. According to a Handelsblatt report, UBS has estimated the additional capital requirement stemming from the proposal at approximately USD 16 billion, with a further USD 2 billion arising from regulatory adjustments.

Since the measure still has to pass through the remaining legislative process, the final shape of future capital requirements remains an open question that continues to weigh on strategic planning. Media reports suggest the bank is preparing for the possibility that parliament could impose extra capital obligations on its overseas operations, with discussed responses ranging from further capital accumulation and scaling back foreign activities to considerations about the headquarters location — though there are currently no indications of concrete steps in that direction.

UBS at a turning point? This analysis reveals what investors need to know now.

Meanwhile, asset management clients have a near-term event to watch: a rights issue for the UBS Mixed Urban real estate fund is scheduled for October 22 to 30, with trading in the subscription rights on the SIX Swiss Exchange set to run from October 22 to 28.

Ad

UBS Stock: New Analysis - 11 October

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

Disclaimer...

en | CH0244767585 | UBS | boerse | 70293126 |